Home » Topics » Regulatory

Regulatory
RSS

Bayer seeks FDA approval for intravenous formulation of Avelox

Nov. 8, 2000

New three-in-one approach to Parkinson's disease

Nov. 8, 2000

Permax approved in Canada as monotherapy for PD

Nov. 8, 2000

DIRECT trial begins for prevention and progression of retinopathy in diabetic patients

Nov. 7, 2000

FDA approves once-daily Videx capsules

Nov. 3, 2000

Use of vasopeptidase inhibitors in angina pectoris claimed by BMS

Nov. 2, 2000

Lanicemine now claimed for treatment of headache

Nov. 2, 2000

Microsponge formulation of 5-FU approved by FDA for actinic keratoses

Oct. 31, 2000

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Oct. 27, 2000

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Oct. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...